CEO: Vicente Anido

Sector: Healthcare

Exchange: NASDAQ Global Market

Country: USA

Description: Aerie Pharmaceuticals Inc is a clinical-stage pharmaceutical company. It is engaged in the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye.


Key numbers

Market Capitalization:1053339540
Shares Outstanding: 46321000
Float: 37754163
Next Earning Date:2020-03-06
TTm EPS: -4.3261
TTm Dividend Rate:
200 days moving average:26.84
50 days moving average: 21.6
One day percent Change: -5.68



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,